BUSINESS● LOWOct 2 · Oct 2, 2026, 11:18 AM
Big Pharma turns to China for new drugs as patent cliff drives multibillion-dollar deals
CNBC · global
Western biopharma companies are increasingly turning to China to source innovation, as pharma's dreaded "patent cliff" draws closer.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESSnowTullow Oil: the slow collapse of a former pillar of African oilJeune AfriqueBUSINESS16m agoServiceNow price target bumped to $170 at Citi on improving AI demandSeeking Alpha Tech